These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 364232)

  • 1. Neurotensin, a biologically active peptide.
    Bissette G; Manberg P; Nemeroff CB; Prange AJ
    Life Sci; 1978 Nov; 23(22):2173-82. PubMed ID: 364232
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurotensin. Immunohistochemical localization in central and peripheral nervous system and in endocrine cells and its functional role as neurotransmitter and endocrine hormone.
    Reinecke M
    Prog Histochem Cytochem; 1985; 16(1):1-172. PubMed ID: 2859633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin.
    Blackburn AM
    J Clin Pathol Suppl (Assoc Clin Pathol); 1978; 8():12-6. PubMed ID: 399607
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neurotensin, a multi-action peptide hormone].
    St-Pierre S; Quirion R; Regoli D; Gervais A; Lavigne F; Poirier A; Jolicoeur F; Barbeau A; Rioux F
    Union Med Can; 1980 Oct; 109(10):1447-55. PubMed ID: 7466969
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and characterization of neurotensin analogues for structure/activity relationship studies. Acetyl-neurotensin-(8--13) is the shortest analogue with full binding and pharmacological activities.
    Granier C; van Rietschoten J; Kitabgi P; Poustis C; Freychet P
    Eur J Biochem; 1982 May; 124(1):117-24. PubMed ID: 7084220
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurotensin: peptide for the next millennium.
    Tyler-McMahon BM; Boules M; Richelson E
    Regul Pept; 2000 Sep; 93(1-3):125-36. PubMed ID: 11033059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on neurotensin as a hormone. Assay and release of neurotensin-like immunoreactivity and effects of neurotensin.
    Rökaeus A
    Acta Physiol Scand Suppl; 1981; 501():1-62. PubMed ID: 6954834
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion.
    Norman C; Beckett SR; Spicer CH; Ashton D; Langlois X; Bennett GW
    J Psychopharmacol; 2008 May; 22(3):300-7. PubMed ID: 18208905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution, localization and characteristics of neurotensin binding sites in the rat brain.
    Lazarus LH; Brown MR; Perrin MH
    Neuropharmacology; 1977 Sep; 16(9):625-9. PubMed ID: 917267
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma concentration of neurotensin-like immunoreactivity (NTLI) and lower esophageal sphincter (LES) pressure in man following infusion of (Gln4)-neurotensin.
    Rosell S; Thor K; Rökaeus A; Nyquist O; Lewenhaupt A; Kager L; Folkers K
    Acta Physiol Scand; 1980 Aug; 109(4):369-75. PubMed ID: 7468258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive analogs of neurotensin: focus on CNS effects.
    Boules M; Fredrickson P; Richelson E
    Peptides; 2006 Oct; 27(10):2523-33. PubMed ID: 16882457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurotensin].
    Wang W; Chen YJ
    Sheng Li Ke Xue Jin Zhan; 1985 Oct; 16(4):312-6. PubMed ID: 2874608
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular effects of neurotensin and some analogues on rats.
    Di Paola ED; Richelson E
    Eur J Pharmacol; 1990 Jan; 175(3):279-83. PubMed ID: 2323349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurotensin].
    Saito S; Saito H
    Nihon Rinsho; 1983 May; 41(5):920-5. PubMed ID: 6138447
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synthesis and biological activity of cyclic and linear analogs of C-terminal fragments of neurotensin].
    Grinshteĭne IV; Misinia IP; Vegner RE; Vosekalna IA; Gaĭlite EA
    Bioorg Khim; 1985 Sep; 11(9):1167-79. PubMed ID: 4062994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and activities of neurotensin, and its acid and amide analogs: possible natural occurrence of [Gln4]-neurotensin.
    Folkers K; Chang D; Humphries J; Carraway R; Leeman SE; Bowers CY
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):3833-7. PubMed ID: 1069268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitization and down-regulation of neurotensin receptors in murine neuroblastoma clone N1E-115 by [D-Lys8] neurotensin(8-13).
    Donato di Paola E; Cusack B; Yamada M; Richelson E
    J Pharmacol Exp Ther; 1993 Jan; 264(1):1-5. PubMed ID: 8380855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of neurotensin in central nervous system pathophysiology: what is the evidence?
    St-Gelais F; Jomphe C; Trudeau LE
    J Psychiatry Neurosci; 2006 Jul; 31(4):229-45. PubMed ID: 16862241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of neurotensin (NT)-induced glucagon release by [D-Trp11]-NT1.
    Ukai M; Itatsu T; Shibata A; Rioux F; St-Pierre S
    Experientia; 1982 Oct; 38(10):1222-4. PubMed ID: 6754419
    [No Abstract]   [Full Text] [Related]  

  • 20. Compound 48/80 inhibits neurotensin-induced hypotension in rats.
    Quirion R; Rioux F; Regoli D; St-Pierre S
    Life Sci; 1980 Nov; 27(20):1889-95. PubMed ID: 6110157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.